| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner. | Mol Cancer Ther | 2013 | 1.24 |
| 2 | The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. | PLoS One | 2012 | 1.23 |
| 3 | Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. | J Mol Cell Biol | 2012 | 1.06 |
| 4 | The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression. | Pigment Cell Melanoma Res | 2010 | 0.95 |
| 5 | Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction. | Blood | 2008 | 0.87 |